3D biomaterial models of human brain disease.
3D culture
Biomaterials
Brain ECM
Brain disease
Brain organoids
Hydrogels
Journal
Neurochemistry international
ISSN: 1872-9754
Titre abrégé: Neurochem Int
Pays: England
ID NLM: 8006959
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
10
11
2020
revised:
21
03
2021
accepted:
06
04
2021
pubmed:
23
4
2021
medline:
18
1
2022
entrez:
22
4
2021
Statut:
ppublish
Résumé
Inherent limitations of the traditional approaches to study brain function and disease, such as rodent models and 2D cell culture platforms, have led to the development of 3D in vitro cell culture systems. These systems, products of multidisciplinary efforts encompassing stem cell biology, materials engineering, and biofabrication, have quickly shown great potential to mimic biochemical composition, structural properties, and cellular morphology and diversity found in the native brain tissue. Crucial to these developments have been the advancements in stem cell technology and cell reprogramming protocols that allow reproducible generation of human subtype-specific neurons and glia in laboratory conditions. At the same time, biomaterials have been designed to provide cells in 3D with a microenvironment that mimics functional and structural aspects of the native extracellular matrix with increasing fidelity. In this article, we review the use of biomaterials in 3D in vitro models of neurological disorders with focus on hydrogel technology and with biochemical composition and physical properties of the in vivo environment as reference.
Identifiants
pubmed: 33887378
pii: S0197-0186(21)00089-9
doi: 10.1016/j.neuint.2021.105043
pii:
doi:
Substances chimiques
Biocompatible Materials
0
Hydrogels
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
105043Informations de copyright
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.